ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 174 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.61 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $685,000 | -12.4% | 43,161 | +20.5% | 0.00% | – |
| Q4 2021 | $782,000 | -47.4% | 35,821 | -28.0% | 0.00% | -100.0% |
| Q3 2021 | $1,487,000 | -45.1% | 49,734 | -18.7% | 0.00% | -50.0% |
| Q2 2021 | $2,710,000 | -39.6% | 61,197 | -39.5% | 0.00% | -33.3% |
| Q1 2021 | $4,485,000 | +77.5% | 101,082 | +119.4% | 0.00% | +50.0% |
| Q4 2020 | $2,527,000 | +704.8% | 46,075 | +235.2% | 0.00% | – |
| Q3 2020 | $314,000 | +8.3% | 13,747 | -0.7% | 0.00% | – |
| Q2 2020 | $290,000 | +93.3% | 13,843 | +29.1% | 0.00% | – |
| Q1 2020 | $150,000 | -72.6% | 10,724 | -55.4% | 0.00% | – |
| Q4 2019 | $548,000 | +103.7% | 24,062 | +4.3% | 0.00% | – |
| Q3 2019 | $269,000 | +44.6% | 23,064 | +85.9% | 0.00% | – |
| Q2 2019 | $186,000 | – | 12,405 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 16,812,491 | $234,534,000 | 10.10% |
| TANG CAPITAL MANAGEMENT LLC | 2,965,485 | $41,369,000 | 5.81% |
| Ghost Tree Capital, LLC | 650,000 | $9,068,000 | 2.40% |
| Boxer Capital, LLC | 1,466,051 | $20,451,000 | 1.39% |
| Vivo Capital, LLC | 860,648 | $12,006,000 | 1.09% |
| Samsara BioCapital, LLC | 128,197 | $1,788,000 | 1.03% |
| Cormorant Asset Management, LP | 1,568,550 | $21,881,000 | 1.02% |
| Perceptive Advisors | 2,189,010 | $30,537,000 | 0.80% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,677,367 | $23,399,000 | 0.74% |
| Eventide Asset Management | 1,415,000 | $19,739,000 | 0.64% |